5-Methoxy-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 98%, 5g

4-(4-(3-(2-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide, 98%, 100mg

5,5-Dimethyl-2-(4-vinylphenyl)-1,3,2-dioxaborinane, 98%, 250mg

(6-BROMO-5-FLUOROPYRIDIN-2-YL)METHANOL, 95.0%, 100mg

(1R,2S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclohexanecarboxylic acid, 95.0%, 250mg

Pyrimidine, 4,6-dichloro-2-(1-naphthalenyl)-, 95%, 100mg

2,2-DIPHENYL-N-[4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-ACETAMIDE, 95%, 50mg

5-(3,4-difluorophenyl)-4,5-dihydroisoxazole-3-carboxylic acid, 2.5g

METHYL 3-METHYLIMIDAZO[1,5-A]PYRAZINE-1-CARBOXYLATE, 95.0%, 250mg

3-Ethoxy-5-hydroxybenzaldehyde, 95.0%, 250mg

3-Butoxyphenol>96.0%(GC)5g

[2,2'-bithiophene]-5,5'-diylbis((5-iodo-2-methylphenyl)methanone), 98%, 5mg

GC capillary column ROTI®Cap-1701, 30 m, 0.53 mm, 2.00 µm, 1 Piece(s)